These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 20084344)

  • 21. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Pellissier JM; Brisson M; Levin MJ
    Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of varicella zoster virus: chronic pain.
    Opstelten W; McElhaney J; Weinberger B; Oaklander AL; Johnson RW
    J Clin Virol; 2010 May; 48 Suppl 1():S8-13. PubMed ID: 20510265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stop shingles in its tracks.
    Lang PO; Hasso Y; Michel JP
    J Fam Pract; 2009 Oct; 58(10):531-4. PubMed ID: 19874731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varicella zoster vaccines.
    Creed R; Satyaprakash A; Ravanfar P
    Dermatol Ther; 2009; 22(2):143-9. PubMed ID: 19335725
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Zoster vaccine live.
    Kockler DR; McCarthy MW
    Pharmacotherapy; 2007 Jul; 27(7):1013-9. PubMed ID: 17594207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination to prevent herpes zoster in older adults.
    Gnann JW
    J Pain; 2008 Jan; 9(1 Suppl 1):S31-6. PubMed ID: 18166463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Shingles vaccine: who should get it?
    Johnson AM
    S D Med; 2006 Aug; 59(8):349-50. PubMed ID: 16941852
    [No Abstract]   [Full Text] [Related]  

  • 28. Zoster Vaccine and the Risk of Postherpetic Neuralgia in Patients Who Developed Herpes Zoster Despite Having Received the Zoster Vaccine.
    Tseng HF; Lewin B; Hales CM; Sy LS; Harpaz R; Bialek S; Luo Y; Jacobsen SJ; Reddy K; Huang PY; Zhang J; Anand S; Bauer EM; Chang J; Tartof SY
    J Infect Dis; 2015 Oct; 212(8):1222-31. PubMed ID: 26038400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Zoster vaccine protects against shingles.
    BMJ; 2013 Apr; 346():f2389. PubMed ID: 23596220
    [No Abstract]   [Full Text] [Related]  

  • 30. Cost-effectiveness of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
    Rothberg MB; Virapongse A; Smith KJ
    Clin Infect Dis; 2007 May; 44(10):1280-8. PubMed ID: 17443464
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Why should older adults receive the shingles vaccine?
    Harkness TL
    J Gerontol Nurs; 2010 Oct; 36(10):51-5. PubMed ID: 20506935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Zoster and postherpetic neuralgia: vaccine prevention is available].
    Belmin J; Jarzebowski W; Lafuente-Lafuente C
    Geriatr Psychol Neuropsychiatr Vieil; 2015 Sep; 13 Suppl 2():15-20. PubMed ID: 26967927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A GVF Zoster Workshop.
    Johnson RW
    J Clin Virol; 2010 May; 48 Suppl 1():S1. PubMed ID: 20510261
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.
    Levin MJ; Schmader K
    Herpes; 2007 Sep; 14 Suppl 2():45-7. PubMed ID: 17939896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of herpes zoster and postherpetic neuralgia].
    Schulzeck S; Gleim M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 Oct; 44(10):644-50; quiz 651. PubMed ID: 19834828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of herpes zoster and its painful and debilitating complications.
    Johnson R; McElhaney J; Pedalino B; Levin M
    Int J Infect Dis; 2007 Nov; 11 Suppl 2():S43-8. PubMed ID: 18162246
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine against herpes zoster halves incidence in older people, finds study.
    Ramsey S
    BMJ; 2013 Apr; 346():f2349. PubMed ID: 23585074
    [No Abstract]   [Full Text] [Related]  

  • 38. Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia.
    Brisson M; Pellissier JM; Levin MJ
    Clin Infect Dis; 2007 Dec; 45(11):1527-9. PubMed ID: 17990240
    [No Abstract]   [Full Text] [Related]  

  • 39. Cost-effectiveness of vaccination against herpes zoster and postherpetic neuralgia: a critical review.
    Kawai K; Preaud E; Baron-Papillon F; Largeron N; Acosta CJ
    Vaccine; 2014 Mar; 32(15):1645-53. PubMed ID: 24534737
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Zoster vaccine live for the prevention of shingles in the elderly patient.
    Zussman J; Young L
    Clin Interv Aging; 2008; 3(2):241-50. PubMed ID: 18686747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.